顺势疗法市场分析及预测(按规模、份额、增长和趋势)2031

  • Report Code : TIPRE00007419
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 257
立即购买

顺势疗法市场规模预计将从 2024 年的 128.9 亿美元增至 2031 年的 420.6 亿美元。预计 2025 年至 2031 年期间,该市场的复合年增长率将达到 18.50%。对植物性补充剂的需求不断增长以及创新顺势疗法药物的推出可能会在未来几年为顺势疗法市场带来新的趋势。

顺势疗法市场分析

生活方式相关疾病和慢性疾病的激增推动了顺势疗法药物的普及。此外,植物性补充剂的日益普及以及新型顺势疗法药物的上市也是推动市场增长的关键因素。不断变化的报销政策和不断增长的医疗支出预计将在未来几年创造充足的机会。

顺势疗法市场概览

预计北美将占据顺势疗法市场的最大份额,而亚太地区预计在预测期内将实现显著的复合年增长率。随着公众越来越认识到顺势疗法的自然、非侵入性方法,以及认为其副作用比传统药物少,对顺势疗法的需求正在激增。全国调查估计,多达 10% 的印度家庭定期使用顺势疗法药物,预计到 2025 年,该国的顺势疗法市场价值将达到 12 亿美元以上。在印度,AYUSH(阿育吠陀、瑜伽和自然疗法、尤那尼、悉达和顺势疗法)部在顺势疗法医学的发展中发挥着关键作用,它通过推广和规范该领域、投资研发、建立 200 多所公认的顺势疗法学院以及将顺势疗法纳入公共卫生计划。截至 2023 年,印度拥有超过 285,000 名注册顺势疗法从业人员,位居世界第一。据印度传统医学部称,包括顺势疗法在内的传统医学领域每年增长超过 17%,预计到 2023 年市场价值将达到约 230 亿美元。

通过投资推广顺势疗法和建立专门机构,印度正在扩大其顺势疗法医疗能力,以满足对替代和预防性医疗保健方法日益增长的需求。

定制此报告以满足您的要求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

顺势疗法市场:

Homeopathy Market
  • 获取此报告的顶级关键市场趋势。
    此免费样品将包括数据分析,从市场趋势到估计和预测。

顺势疗法市场驱动因素和机遇

顺势疗法的采用率激增

据世界卫生组织 (WHO) 统计,顺势疗法被公认为发展最快、规模第二大的医学体系。据世界卫生组织统计,在42个欧洲国家中,有40个国家/地区已实施并可行顺势疗法。在法国,95%的全科医生、儿科医生和皮肤科医生在其诊疗过程中采用顺势疗法。瑞士政府最近得出结论,顺势疗法“有效、经济且安全”,并承认其与传统医学享有同等地位。此外,《英国医学杂志》报道,德国有高达57%的人使用顺势疗法。

印度依靠顺势疗法进行医疗护理的人数位居世界首位,有1亿人完全依赖这种治疗方式。顺势疗法是印度政府和公众在传统医学(AYUSH)下获得第二多资助、应用最多的类别。AYUSH部通过投资基础设施和教育,积极推广和规范顺势疗法。2024年3月,印度在北印度建立了第一所公立顺势疗法学院,并获得了8亿印度卢比的投资。因此,顺势疗法从业人员数量的增加以及政府推广顺势疗法的举措,促进了顺势疗法市场的增长。

医疗支出激增和报销政策变化  

顺势疗法正日益融入国家医疗保健体系和保险框架,尤其是在亚洲和欧洲国家。在德国、法国和印度等国家,相当一部分人口可以通过公共或私人医疗保险获得顺势疗法治疗。然而,欧洲各地的报销水平各不相同。

印度尤其成为其公共卫生网络中顺势疗法的主要枢纽。顺势疗法是继阿育吠陀之后第二广泛使用的印度传统医学(AYUSH)疗法。顺势疗法医疗中心占印度所有AYUSH中心的31%。根据印度国家卫生框架,超过7000种疾病被正式认定为可以通过顺势疗法治疗。

在中东,保险公司传统上不愿承保顺势疗法;然而,这种态度正在改变。阿联酋等中东国家已开始在卫生部和迪拜卫生局(DHA)注册顺势疗法执业医师,以促进更广泛的包容性和监管。公众对替代医学的需求日益增长,执业医师数量不断增加,以及支持顺势疗法成本效益的证据(尤其是在治疗慢性疾病方面),可能会鼓励保险公司开始更频繁地报销顺势疗法治疗费用,即使与传统疗法同时使用。

因此,随着医疗支出增加和保险覆盖范围扩大,国家卫生体系的纳入程度不断提高,预计将在未来几年为顺势疗法市场创造充足的机会。

顺势疗法市场报告细分分析

顺势疗法市场分析的基础关键部分是来源、类型、应用和最终用户。

  • 根据来源,顺势疗法市场分为植物、矿物质和动物。2024年,植物类药物占据了顺势疗法市场的最大份额,预计在2025年至2031年期间将实现更高的复合年增长率。
  • 按类型划分,顺势疗法市场分为稀释剂、酊剂、生化制剂、片剂、软膏剂和其他。稀释剂在2024年占据顺势疗法市场的最大份额,预计在2025年至2031年期间将实现最高的复合年增长率。
  • 根据应用,顺势疗法市场分为神经病学、胃肠病学、呼吸病学、皮肤病学和免疫学。2024年,神经病学领域占据了顺势疗法市场的最大份额。
  • 根据终端用户,顺势疗法市场可细分为顺势疗法诊所、零售药店、电子零售商和其他。顺势疗法诊所在2024年占据了顺势疗法市场的最大份额,预计在2025年至2031年期间将实现最高的复合年增长率。

顺势疗法市场份额(按地区)分析

顺势疗法市场报告的地理范围主要分为五个区域:北美、亚太地区、欧洲、中东和非洲以及南美和中美。2024年,北美占据了相当大的市场份额。在北美,对创新顺势疗法的需求日益增长,包括已被证明可有效治疗呼吸系统疾病的基因靶向药物和制剂。在美国,大量成人和儿童使用顺势疗法来解决健康问题,这表明替代疗法的接受度越来越高。目前,主要的区域零售商除了提供传统药物外,还提供各种各样的顺势疗法产品。在美国和加拿大,患者正在转向顺势疗法来治疗慢性疾病、缓解压力和预防性保健。Boiron Co.和Homeocan Inc.等领先公司提供全面的产品系列,包括顺势疗法片剂、酊剂、乳膏和软膏。这些公司强调法规合规性和质量保证,确保其产品符合安全性和有效性标准。顺势疗法注重个性化护理等原则的整体性,引起了对早期症状治疗和疾病预防感兴趣的消费者的共鸣。

患者教育在市场扩张中发挥着至关重要的作用。如今,持证顺势疗法医师、自然疗法医生和在线咨询平台提供关于使用和选择顺势疗法药物的专业指导。像 Daleila Medica 这样的专业药房以及科学临床试验有助于增强顺势疗法的可信度,提升消费者信心。草药提取物和其他天然产品经常被纳入其中,这反映了人们越来越倾向于采用自然健康解决方案。正在进行的研究正在持续探索顺势疗法对过敏、呼吸系统疾病、睡眠障碍和免疫健康等疾病的有效性。

顺势疗法市场不断扩张,吸引了众多寻求通过顺势疗法、草药疗法和生活方式调整相结合来预防疾病、管理慢性健康状况并促进整体健康的消费者。此外,关于传统中医和顺势疗法的教育也正在提升消费者的知识,并塑造该领域医疗保健提供者的专业技能。

 

顺势疗法市场区域洞察

Insight Partners 的分析师已详尽阐述了预测期内影响顺势疗法市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的顺势疗法市场细分和地域分布。

顺势疗法市场报告范围

报告属性细节
2024年的市场规模128.9亿美元
2031年的市场规模420.6亿美元
全球复合年增长率(2025-2031)18.5%
史料2021-2023
预测期2025-2031
涵盖的领域按来源
  • 植物
  • 矿物质
  • 动物
按类型
  • 稀释
  • 酊剂
  • 生物化学
  • 平板电脑
  • 软膏
  • 其他的
按应用
  • 神经病学
  • 胃肠病学
  • 呼吸系统
  • 皮肤科
  • 免疫学
  • 其他的
按最终用户
  • 顺势疗法诊所
  • 零售药店
  • 电子零售商
  • 其他的
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 福尔茨
  • 布瓦龙
  • 海尔米特尔生物制品有限公司
  • 雷克韦格博士有限公司
  • Homeocan公司
  • Dr. Schwabe Holding SE & Co. KG
  • 哈内曼实验室有限公司
  • Qvik - 顺势疗法
  • 赫弗特-阿兹内米特尔有限公司两合公司。
  • 自然

 

顺势疗法市场参与者密度:了解其对业务动态的影响

顺势疗法市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求的驱动因素包括消费者偏好的演变、技术进步以及对产品益处的认知度的提升。随着需求的增长,企业正在扩展产品线,不断创新以满足消费者需求,并抓住新兴趋势,从而进一步推动市场增长。


Homeopathy Market

 

  • 获取顺势疗法市场顶级关键参与者概览

顺势疗法市场新闻和最新发展

顺势疗法市场评估通过收集一手资料和二手资料进行定性和定量分析,这些数据包括重要的企业出版物、协会数据和数据库。市场的主要发展情况如下:

  • Dr. Schwabe Holding SE & Co. KG 增持了其于 2020 年收购的 Braineffect 公司的股份,目前持有这家总部位于柏林、开发营养补充剂和功能性食品的公司的多数股权。Dr. Schwabe Holding SE & Co. KG 旨在通过此次收购增强其产品线。(来源:Dr. Schwabe Holding SE & Co. KG,公司网站,2025 年)
  • Boiron 扩大了其产品线,推出了 ThroatCalm 喷雾,这是其备受信赖的 ThroatCalm 系列的最新成员。该产品的推出进一步增强了公司的产品组合。(来源:Boiron,公司网站,2024 年)
  • EW Healthcare Partners 宣布收购 Boiron 25% 的少数股权,旨在进一步加速 Boiron 的增长,将产品拓展至更多医疗保健垂直领域,并利用现有平台推出更多产品,尤其是在美国市场。(来源:EW Healthcare Partners,公司网站,2023 年)

顺势疗法市场报告覆盖范围和交付成果

《顺势疗法市场规模和预测(2021-2031)》报告对市场进行了详细分析,涵盖以下领域:

  • 顺势疗法市场规模及全球、区域和国家层面所有主要细分市场的预测
  • 顺势疗法市场趋势以及市场动态,例如驱动因素、限制因素和关键机遇
  • 详细的 PEST 和 SWOT 分析
  • 顺势疗法市场分析涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及顺势疗法市场的最新发展
  • 详细的公司简介
  • 历史分析(2 年)、基准年、预测(7 年)及复合年增长率
  • PEST 和 SWOT 分析
  • 市场规模价值/数量 - 全球、区域、国家
  • 行业和竞争格局
  • Excel 数据集
homeopathy-market-report-deliverables-img1
homeopathy-market-report-deliverables-img2
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

常见问题


What would be the estimated value of the homeopathy market by 2031?

The homeopathy market is estimated to reach a value of US$ 42.06 billion by 2031.

What are the factors driving the homeopathy market?

The rising adoption of homeopathic medicine and surging prevalence of lifestyle and chronic diseases are among the noteworthy factors contributing to the market growth.

What is the expected CAGR of the homeopathy market?

The homeopathy market is estimated to register a CAGR of 18.5% during the forecast period.

Which are the leading players operating in the homeopathy market?

Fourrts; Boiron; Biologische Heilmittel Heel Gmbh; Dr Reckeweg & Co GmbH; Homeocan Inc; Dr. Schwabe Holding SE & Co. KG; Hahnemann Laboratories, Inc; Qvik – Homeopathy; Hevert-Arzneimittel GmbH & Co. KG.; Natura; and Fusion Homoeopathics are among the key players operating in the homeopathy market.

Which region dominated the homeopathy market in 2024?

Asia Pacific dominated the market in 2024.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies - Homeopathy Market 

  1. Fourrts
  2. Allen Healthcare Co. Ltd.
  3. Hahnemann Laboratories, Inc
  4. Boiron
  5. Homeocan Inc
  6. Hyland's, Inc.
  7. Nelson Pharmacies Limited 
  8. Weleda UK Ltd 
  9. Biologische Heilmittel Heel GmbH 
  10. Ainsworths (London) Limited 
  11. DHU-Arzneimittel GmbH & Co. KG 
  12. Dr Reckeweg & Co GmbH
  13. Similasan Corp
  14. PEKANA Naturheilmittel GmbH
  15. Helios Homeopathy
  16. Bakson
  17. Schwabe Group
  18. BioIndia Pharma
  19. Dr. Willmar Schwabe GmbH & Co. KG
  20. SBL
  21. Hevert-Arzneimittel GmbH & Co. KG
  22. Bioforce
homeopathy-market-cagr

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.